Antiviral activity of double‐stranded RNA‐binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase

Abstract

PACT is a double-stranded RNA-binding protein that has been implicated in host-influenza A virus (IAV) interaction. PACT facilitates the action of RIG-I in the activation of the type I IFN response, which is suppressed by the viral nonstructural protein NS1. PACT is also known to interact with the IAV RNA polymerase subunit PA. Exactly how PACT exerts its antiviral activity during IAV infection remains to be elucidated. In the current study, we demonstrated the interplay between PACT and IAV polymerase. Induction of IFN-β by the IAV RNP complex was most robust when both RIG-I and PACT were expressed. PACT-dependent activation of IFN-β production was suppressed by the IAV polymerase subunits, polymerase acidic protein, polymerase basic protein 1 (PB1), and PB2. PACT associated with PA, PB1, and PB2. Compromising PACT in IAV-infected A549 cells resulted in the augmentation of viral RNA (vRNA) transcription and replication and IFN-β production. Furthermore, vRNA replication was boosted by knockdown of PACT in both A549 cells and IFN-deficient Vero cells. Thus, the antiviral activity of PACT is mediated primarily via its interaction with and inhibition of IAV polymerase. Taken together, our findings reveal a new facet of the host-IAV interaction in which the interplay between PACT and IAV polymerase affects the outcome of viral infection and antiviral response.-Chan, C.-P., Yuen, C.-K., Cheung, P.-H. H., Fung, S.-Y., Lui, P.-Y., Chen, H., Kok, K.-H., Jin, D.-Y. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.

Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC

“…qRT-PCR was carried out essentially as previously described (46,47). In brief, total RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany).…”

“…The RNA interference (RNAi) experiment was performed as previously described (45,47). Short interfering RNAs (siRNAs) were transfected into THP-1 cells with Lipofectamine 2000 48 h before infection with SARS-CoV.…”

PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction

“…HEK293T cells were maintained in DMEM (Life Technologies) with 10% FBS (Life Technologies) as described. 31 Plasmid transfection to HEK293T cells was performed with Gene-Juice (Novagen, Gibbstown, NJ, USA) according to manufacturer's protocol. Plasmid transfection to THP-1 cells was performed with GeneXPlus (ATCC) according to manufacturer's protocol.…”

“…32 Recombinant IAVs WSN-PF and WSN-PΔF were rescued and titrated as previously described. 31 and Western blotting using the appropriate antibodies as described. 29 For co-immunoprecipitation assay, cells were lysed in NP40 lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA, 1% NP-40 and 0.5% sodium deoxycholate) and the target proteins were immunoprecipitated as described.…”

Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication

“…Compromising PACT in IAV-infected A549 cells led to the enhancement of vRNA transcription and replication and IFNβ production. In addition, vRNA replication was increased by knocking down PACT in both A549 cells and IFN-insufficient Vero cells 28 .…”